⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17240311 | 0.55 | — | — | |
| SCHEMBL6299692 | 0.54 | — | — | |
| SCHEMBL2693105 | 0.53 | — | — | |
| Cyclooctane SCHEMBL14861339 | 0.53 | — | — | |
| SCHEMBL1450836 | 0.48 | — | — | |
| SCHEMBL452580 | 0.38 | — | — | |
| SCHEMBL561897 | 0.34 | — | — | |
| SCHEMBL5472732 | 0.25 | — | — | |
| Iodide SCHEMBL21886 | 0.25 | — | — | |
| Iodide SCHEMBL6053672 | 0.25 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9287 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115819413-A | Carbazole-based small-molecule compound, method and organic all-optical synapse based on illumination history-dependent fluorescence intensity mechanism | 中国科学院大学 | 2023-03-21 | — | — | CN | claimed |
| US-20220389004-A1 | FUSED IMIDAZOPYRIDINES AS REVERSIBLE INHIBITORS OF BRUTONS TYROSINE KINASE (BTK) | EMD Serono Research and Development Institute, Inc. | 2022-12-08 | — | — | US | claimed |
| EP-3843847-A1 | FUSED IMIDAZOPYRIDINES AS REVERSIBLE INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK) | Merck Patent GmbH (DE) | 2021-07-07 | — | — | EP | claimed |
| EP-3253764-B1 | MACROCYCLIC COMPOUNDS AS IRAK1/4 INHIBITORS AND USES THEREOF | MERCK PATENT GMBH (DE) | 2021-06-09 | — | — | EP | claimed |
| CN-112930213-A | Fused imidazopyridines as reversible inhibitors of Bruton's Tyrosine Kinase (BTK) | 默克专利有限公司 | 2021-06-08 | — | — | CN | claimed |
| US-20200246274-A1 | GLUTAMINASE INHIBITOR DISCOVERY AND NANOPARTICLE-ENHANCED DELIVERY FOR CANCER THERAPY | THE JOHNS HOPKINS UNIVERSITY | 2020-08-06 | — | — | US | claimed |
| WO-2020043638-A1 | FUSED IMIDAZOPYRIDINES AS REVERSIBLE INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK) | MERCK PATENT GMBH (DE) | 2020-03-05 | — | — | WO | claimed |
| EP-2692777-B1 | PHARMACEUTICAL COMPOSITION CONTAINING BLOCK COPOLYMER COMPRISING BORONIC ACID COMPOUND | NANOCARRIER CO LTD (JP) | 2018-10-31 | — | — | EP | claimed |
| US-20180207152-A1 | ANTICOAGULANT REVERSAL AGENTS | CIRAPARANTAG HOLDINGS GMBH (CH) | 2018-07-26 | — | — | US | claimed |
| US-9815836-B2 | Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof | MERCK PATENT GMBH (DE) | 2017-11-14 | — | — | US | claimed |
| US-6342503-B1 | ANTIDEPRESSANTS, EATING DISORDERS | DUPONT PHARMACEUTICALS COMPANY | 2002-01-29 | — | — | US | claimed |
| WO-2002006280-A2 | INHIBITORS OF FACTOR Xa | MILLENNIUM PHARAMACEUTICALS, INC. (US) | 2002-01-24 | — | — | WO | claimed |
| US-6326368-B1 | PSYCHOLOGICAL DISORDERS | DUPONT PHARMACEUTICALS COMPANY | 2001-12-04 | — | — | US | claimed |
| EP-1150948-A1 | ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa | COR THERAPEUTICS, INC. (US) | 2001-11-07 | — | — | EP | claimed |
| US-6124302-A | TREATING HIV INFECTIONS | DUPONT PHARMACEUTICALS (US) | 2000-09-26 | — | — | US | claimed |
| US-6107301-A | PSYCHOLOGICAL DISORDERS | DUPONT PHARMACEUTICALS COMPANY (US) | 2000-08-22 | — | — | US | claimed |
| WO-2000047553-A2 | ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa | COR THERAPEUTICS INC. (US) | 2000-08-17 | — | — | WO | claimed |
| EP-0759917-B1 | NOVEL SELECTIVE INHIBITORS OF VIRAL OR BACTERIAL NEURAMINIDASES | GILEAD SCIENCES INC (US) | 2000-04-12 | — | — | EP | claimed |
| EP-0723533-A1 | 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-07-31 | — | — | EP | claimed |
| WO-1995010506-A1 | 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-04-20 | — | — | WO | claimed |